Bimeda is pleased to announce its acquisition of the Grupo Unipharm veterinary medicine portfolio, consisting of 25 licensed veterinary products and over 150 licenses. The acquisition will further strengthen Bimeda’s presence in Central America, which is regarded as a region with significant growth potential. Carlos Porragas, Bimeda Director for Latin America, commented; ‘it is with great pleasure that we announce the acquisition of Grupo Unipharm’s licensed veterinary medicinal product portfolio. The Central American region is one with significant potential for long-term sustainable growth, and increasing our presence here is a critical part of Bimeda’s LATAM commercial strategy. The acquired portfolio…

Bimeda is pleased to be attending the 2016 World Buiatrics Congress, which is taking place in Dublin this year and which is attended by over 3000 delegates. Bimeda’s wide range of animal health and veterinary pharmaceutical products and their global footprint, means that the Bimeda trade stand is proving extremely popular with congress delegates. Bimeda representatives from Ireland, Brazil, the UK and China were on hand to talk to delegates about key health issues affecting cattle globally, and about Bimeda products and services. Bimeda offer a wide range of products which are suitable for use in both dairy and beef…

Bimeda was delighted to welcome delegates to the 2016 IPVS Congress (Irish Pig Veterinary Society) to Dublin this week, with a networking champagne reception which was hosted at the Herbert Park Hotel in Ballsbridge. Around 80 delegates were in attendance, with pig vets and veterinary pharmaceutical professionals from Spain, Ireland, Russia, Slovakia,  the UK, the Netherlands, Belgium, Guatemala and other countries coming along to the event. Bimeda manufactures and markets a wide range of veterinary pharmaceuticals and animal health products, with a presence in over 70 countries worldwide. The company markets a wide range of products which are licensed for…